The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Amgen; GlaxoSmithKline/Tesaro
Speakers' Bureau - AstraZeneca; Clovis Oncology; GlaxoSmithKline/Tesaro; PharmaMar; Roche
Travel, Accommodations, Expenses - GlaxoSmithKline/Tesaro; PharmaMar

ENGOT-EN6/NSGO-RUBY: A phase III, randomized, double-blind, multicenter study of dostarlimab + carboplatin-paclitaxel versus placebo + carboplatin-paclitaxel in recurrent or primary advanced endometrial cancer (EC).
 
Mansoor Raza Mirza
Leadership - Karyopharm Therapeutics; SeraCare
Stock and Other Ownership Interests - Karyopharm Therapeutics; SeraCare
Honoraria - Advaxis; AstraZeneca; Cerulean Pharma; Clovis Oncology; Novocure; Pfizer; Roche; tesaro
Consulting or Advisory Role - AstraZeneca; BioCad; Cerulean Pharma; Clovis Oncology; Genmab; Karyopharm Therapeutics; Novocure; Pfizer; Sotio; Tesaro
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Clovis Oncology (Inst); Pfizer (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Karyopharm Therapeutics; Pfizer; Roche; SeraCare; Tesaro
 
Robert L. Coleman
Consulting or Advisory Role - Abbvie; Abbvie/Stemcentrx; Agenus; AstraZeneca/MedImmune; Clovis Oncology; Esperance Pharmaceuticals; Genentech/Roche; Genmab; Immunogen; Novocure; Oncolytics; OncoMed; OncoSec; Sotio; Tesaro
Research Funding - Abbott/AbbVie; Array BioPharma; AstraZeneca/MedImmune; Clovis Oncology; Esperance Pharmaceuticals; Johnson & Johnson; Merck; OncoMed; Roche/Genentech
Travel, Accommodations, Expenses - Array BioPharma; AstraZeneca/MedImmune; Clovis Oncology; Clovis Oncology; GOG Foundation; Merck; Research to Practice; Roche/Genentech; Sotio; Vaniam Group
 
Lars Christian Hanker
Consulting or Advisory Role - Amgen; AstraZeneca; Clovis Oncology; Roche Pharma AG; Tesaro
Travel, Accommodations, Expenses - AstraZeneca; Intuitive Surgical; PharmaMar; Roche Pharma AG; Tesaro
 
Brian M. Slomovitz
Consulting or Advisory Role - GlaxoSmithKline
 
Giorgio Valabrega
No Relationships to Disclose
 
Ellie Im
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Monica Walker
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - Tesaro
Travel, Accommodations, Expenses - Tesaro
 
Wei Guo
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Matthew A. Powell
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Roche/Genentech; Tesaro
Speakers' Bureau - AstraZeneca; Clovis Oncology; Genentech/Roche; Tesaro